Biosynthetic Pathways of Lincosamide Antibiotics

Lincosamide antibiotics, typified by lincomycin and celesticetin, are characterised by a unique linkage between an amino sugar and an amino acid–derived moiety. These compounds are assembled by actinomycete bacteria via a multi‐step pathway that combines elements of nonribosomal peptide synthesis, mycothiol‐dependent transformations and specialised tailoring enzymes. The biosynthesis begins with the formation of a 4-alkyl-L-proline derivative from L-tyrosine through a series of unusual enzyme-catalysed reactions including C–C bond cleavage and methylation. This alkylproline unit is then activated by an adenylation domain and tethered to a carrier protein, while the sugar moiety is processed via a mycothiol‐dependent detoxification‐like system to yield a mercapturic acid intermediate. A dedicated condensation enzyme subsequently forges the amide bond between these two building blocks, employing a hybrid mechanism distinct from classical peptide synthetases. The final stages involve deacetylation, oxidative modifications and acyl transfer steps to release the mature antibiotic. Regulation of lincosamide gene clusters is orchestrated via cluster-situated regulators, global transcription factors and feedback circuits that respond to intracellular signals and environmental cues. Advances in structural biology and enzymology have enabled rational engineering of pathway enzymes, unlocking the potential to generate novel lincosamide analogues with improved pharmacological properties.

Research from Nature Portfolio

Recent studies have elucidated the structural basis of the key condensation enzyme responsible for amide bond formation in lincosamide biosynthesis. High-resolution crystallography revealed that this enzyme adopts an unexpected fold with an N-terminal region reminiscent of cysteine proteases and utilises a Cys-His-Glu catalytic triad to couple a carrier protein-tethered amino acid to a thiooctose sugar. Biochemical assays demonstrated broad substrate tolerance, facilitating the synthesis of unnatural lincosamide structures. In another breakthrough, the bifurcation of lincomycin and celesticetin pathways was shown to arise from two pyridoxal 5′-phosphate-dependent enzymes acting on the same S-glycosyl-L-cysteine intermediate. Combined X-ray structures, docking and molecular dynamics highlighted how active-site aromatic residues dictate whether the reaction proceeds via β-elimination or decarboxylation-coupled oxidative deamination. Structure-guided mutagenesis successfully swapped enzyme functions and endowed both proteins with new oxidative-amidation activity, demonstrating a route to expand lincosamide chemical diversity through enzyme engineering.

Biosynthetic Pathways of Lincosamide Antibiotics publication trend

The graph below shows the total number of articles in biosynthetic pathways of lincosamide antibiotics across all publications each year (not limited to Nature Index journals).

Technical terms

Biosynthetic gene cluster (BGC): Co-localised set of genes encoding enzymes and regulators for natural product biosynthesis.

Carrier protein (CP): Small protein that temporarily tethers intermediates during nonribosomal and hybrid enzyme assembly processes.

Pyridoxal 5′-phosphate (PLP): Vitamin B6-derived cofactor enabling aminotransfer, decarboxylation and elimination reactions.

Nonribosomal peptide synthetase (NRPS): Modular enzyme complex assembling peptide-based natural products independently of the ribosome.

ABCF ATPase: ATP-binding cassette family F protein that interacts with the ribosome to confer antibiotic resistance and signalling.

References

1. Biosynthesis and incorporation of an alkylproline-derivative (APD) precursor into complex natural products. Natural Product Reports (2018).
2. Lincosamide Synthetase—A Unique Condensation System Combining Elements of Nonribosomal Peptide Synthetase and Mycothiol Metabolism. PLOS ONE (2015).
3. Deacetylation of mycothiol-derived ‘waste product’ triggers the last biosynthetic steps of lincosamide antibiotics. Chemical Science (2016).
4. Elucidation of salicylate attachment in celesticetin biosynthesis opens the door to create a library of more efficient hybrid lincosamide antibiotics. Chemical Science (2017).
5. Molecular basis for carrier protein-dependent amide bond formation in the biosynthesis of lincosamide antibiotics. Nature Catalysis (2023).
6. Molecular basis for the diversification of lincosamide biosynthesis by pyridoxal phosphate-dependent enzymes. Nature Chemistry (2024).
7. Three new LmbU targets outside lmb cluster inhibit lincomycin biosynthesis in Streptomyces lincolnensis. Microbial Cell Factories (2024).
8. Beyond Self-Resistance: ABCF ATPase LmrC Is a Signal-Transducing Component of an Antibiotic-Driven Signaling Cascade Accelerating the Onset of Lincomycin Biosynthesis. mBio (2021).